Article

Development of Novel Measures for Alzheimer’s Disease Prevention Trials (NoMAD)

2021-01-16

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> Assessment of cognition and everyday function is essential in clinical trials for Alzheimer’s disease (AD). Two novel measures of cognition (No Practice Effects (NPE) cognitive battery and Miami Computerized Functional Assessment Scale (CFAS)) were designed to have robust psychometric properties and reduced practice and ceiling effects. This study aims to evaluate if the NPE...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6a69b6f2-38fc-535d-b738-f6205c6f40fa
DOI: 10.1101/2021.01.13.21249627

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of Novel Measures for Alzheimer’s Disease Prevention Trials (NoMAD)DOI 10.1101/2021.01.13.21249627Read

Remote Digital Cognitive Assessment in a Trial-Ready Alzheimer’s Cohort: A Scalable Approach for Early Intervention StudiesSemantic proximity Read

Predicting Alzheimer's disease with practice effects, APOE genotype and brain metabolism.Semantic proximity Read

The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.Semantic proximity Read

Cognition or genetics? Predicting Alzheimer's disease with practice effects, APOE genotype, and brain metabolism.Semantic proximity Read

A Machine Learning Approach to Predict Cognitive Decline in Alzheimer’s Disease Clinical TrialsSemantic proximity Read

Is Preventive Adapted Physical Activity a Tool for Screening in Patients With MCI (Mild Cognitive Impairment) and a Tool to Reduce Ad (Alzheimer’s Disease) Impairments Long-term? A Systematic Review.Semantic proximity Read

Measuring Subjective Cognitive Decline in Older Adults: Harmonization between the Cognitive Change Index and the Measurement of Everyday Cognition InstrumentsSemantic proximity Read

Validity and cultural generalisability of a 5-minute AI-based, computerised cognitive assessment in Mild Cognitive Impairment and Alzheimer’s DementiaSemantic proximity Read

Reliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multicenter research studies.Semantic proximity Read

Utility of the ADAS-Cog as a Cognitive Screening Tool in Older Adults with Epilepsy: A Multicenter Cohort StudySemantic proximity Read

Remote cognitive tests predict neurodegenerative biomarkers in the Insight 46 cohortSemantic proximity Read

Concurrent Detection of Cognitive Impairment and Amyloid Positivity with a Next-Generation Digital Cognitive AssessmentSemantic proximity Read